Home › Ulcerative Colitis › Colorado › Colorado Springs
Pag-aaral pangklinika para sa Ulcerative Colitis sa Colorado Springs, CO
14 pag-aaral para sa Ulcerative Colitis ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Colorado Springs (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Nagre-recruitPhase 2
- Peak Gastroenterology Associates - Colorado Springs - North Cascade Avenue /ID# 280507, Colorado Springs
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 2
- Peak Gastroenterology Associates, Colorado Springs
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Nagre-recruitPhase 4
- Peak Gastroenterology Associates, Colorado Springs
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Nagre-recruitPhase 2
- Site 033, Colorado Springs
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Nagre-recruitPhase 2
- Peak Gastroenterology Associates, Colorado Springs
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
Nagre-recruitPhase 2
- Peak Gastroenterology Associates ( Site 1052), Colorado Springs
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 3
- Peak Gastroenterology Associates, Colorado Springs
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 2
- Peak Gastroenterology Associates, Colorado Springs
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Nagre-recruitPhase 2
- Peak Gastroenterology Associates, Colorado Springs
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 3
- Peak Gastroenterology Associates - Colorado Springs - Site Number: 8400039, Colorado Springs
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 3
- Peak Gastroenterology Associates, Colorado Springs
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Nagre-recruitPhase 2
- Peak Gastroenterology Associates, Colorado Springs
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Nagre-recruitPhase 3
- Peak Gastroenterology Associates - Colorado Springs - Site Number: 8400039, Colorado Springs
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Nagre-recruitPhase 2
- Mirador Therapeutics Selected Site, Colorado Springs
Pag-aaral para sa Ulcerative Colitis sa ibang lungsod
- New York City, NY23 pag-aaral
- Orlando, FL22 pag-aaral
- Miami, FL21 pag-aaral
- Houston, TX17 pag-aaral
- San Antonio, TX16 pag-aaral
- Tyler, TX15 pag-aaral
- Tacoma, WA15 pag-aaral
- Chicago, IL15 pag-aaral
- San Diego, CA15 pag-aaral
- Los Angeles, CA13 pag-aaral
- St. Louis, MO13 pag-aaral
- Washington, DC12 pag-aaral
Iba pang pag-aaral sa Colorado Springs
- Crohn's Disease13 pag-aaral
- Kanser sa Prostate12 pag-aaral
- Non-Small Cell Lung Cancer11 pag-aaral
- Kanser sa Baga8 pag-aaral
- Kanser sa Suso7 pag-aaral
- Asthma6 pag-aaral
- Colon Cancer6 pag-aaral
- Colorectal Cancer6 pag-aaral
- Rectal Cancer4 pag-aaral
- Mga Karamdaman sa Labis na Pagkatulog4 pag-aaral
- Inflammatory Bowel Disease4 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg4 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.